Company Filing History:
5 out of 42 
3 out of 3 
2 out of 2 Years Active: 1992-2022
Title: The Innovative Journey of Marit Otterlei
Introduction
Marit Otterlei is a prominent inventor based in Trondheim, Norway, known for her significant contributions to the fields of biotechnology and therapeutic innovation. With a total of 11 patents to her name, she has made remarkable strides in developing agents aimed at tackling bacterial infections and regulating immune responses.
Latest Patents
Otterlei's latest patents reflect her dedication to advancing therapeutic options. One of her noteworthy inventions is centered around antimicrobial agents and their application in therapy. This invention provides a composition designed to treat or prevent bacterial infections, potentially enhancing the efficacy of antibiotics when used in combination with other active agents.
Another significant patent by Otterlei involves immunosuppressive agents, which are aimed at treating hypercytokinemia. This condition stems from cytokine release by immune cells and can lead to severe health consequences. Her innovative agent includes specific oligopeptidic compounds that facilitate cellular uptake and can be utilized in conjunction with other treatments, such as kinase inhibitors.
Career Highlights
Throughout her career, Marit Otterlei has worked with esteemed organizations, notably the Norwegian University of Science and Technology and Apim Therapeutics AS. Her research endeavors have significantly contributed to the advancement of therapeutic modalities targeting critical health challenges.
Collaborations
Collaboration has been a cornerstone of Otterlei's career. She has worked alongside notable professionals in her field, including Terje Espevik and Per Arne Aas. These partnerships have undoubtedly enriched her research and innovation journey, leading to groundbreaking discoveries and patented inventions.
Conclusion
Marit Otterlei's innovative work exemplifies the impact of research and invention in healthcare. Her patents not only pave the way for new therapeutic agents but also reflect her commitment to improving patient outcomes. As she continues to advance her research, the future looks promising for the medical community, thanks to her pioneering efforts.